WELLCOME SHARE FLOAT "MANAGERS"
Following the recent announcement of its decision to float a further bank of shares in Wellcome plc, the Wellcome Trust has appointed lead managers to handle the international sale.
UK-based merchant bank Robert Fleming has already been named as global coordinator for the sell-off (and regional lead manager for territories not specifically allocated as follows), and Baring Bros is Wellcome's advisor. The regional syndicates are: Cazenove for the UK; Morgan Stanley, Lehman Bros and Merrill Lynch for the USA; and Nikko Securities and Nomura for Japan. Elsewhere, Swiss Bank Corp takes over responsibility for Switzerland, Credit Lyonnais and Banque Indosuez for France, Dresdner Bank and Deutsche Bank for Germany and Jardine Fleming for the Pacific Rim.
The sale is reportedly scheduled for July, but it is still dependent on market conditions. At the current L 10.49 per share (at time of riting), the Wellcome sale is, nevertheless, expected to be prestigious.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze